Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

882 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Foscarnet against human herpesvirus (HHV)-6 reactivation after allo-SCT: breakthrough HHV-6 encephalitis following antiviral prophylaxis.
Ogata M, Satou T, Inoue Y, Takano K, Ikebe T, Ando T, Ikewaki J, Kohno K, Nishida A, Saburi M, Miyazaki Y, Ohtsuka E, Saburi Y, Fukuda T, Kadota J. Ogata M, et al. Among authors: nishida a. Bone Marrow Transplant. 2013 Feb;48(2):257-64. doi: 10.1038/bmt.2012.121. Epub 2012 Jul 2. Bone Marrow Transplant. 2013. PMID: 22750998
Anti-HLA antibodies other than against HLA-A, -B, -DRB1 adversely affect engraftment and nonrelapse mortality in HLA-mismatched single cord blood transplantation: possible implications of unrecognized donor-specific antibodies.
Yamamoto H, Uchida N, Matsuno N, Ota H, Kageyama K, Wada S, Kaji D, Nishida A, Ishiwata K, Takagi S, Tsuji M, Asano-Mori Y, Yamamoto G, Izutsu K, Masuoka K, Wake A, Yoneyama A, Makino S, Taniguchi S. Yamamoto H, et al. Among authors: nishida a. Biol Blood Marrow Transplant. 2014 Oct;20(10):1634-40. doi: 10.1016/j.bbmt.2014.06.024. Epub 2014 Jun 24. Biol Blood Marrow Transplant. 2014. PMID: 24972251 Free article.
I.v. BU/fludarabine plus melphalan or TBI in unrelated cord blood transplantation for high-risk hematological diseases.
Yamamoto H, Uchida N, Matsuno N, Kon A, Nishida A, Ota H, Ikebe T, Nakano N, Ishiwata K, Araoka H, Takagi S, Tsuji M, Asano-Mori Y, Yamamoto G, Izutsu K, Masuoka K, Wake A, Yoneyama A, Makino S, Taniguchi S. Yamamoto H, et al. Among authors: nishida a. Bone Marrow Transplant. 2015 Apr;50(4):607-9. doi: 10.1038/bmt.2014.316. Epub 2015 Jan 26. Bone Marrow Transplant. 2015. PMID: 25621796 No abstract available.
Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
Kimura M, Araoka H, Yoshida A, Yamamoto H, Abe M, Okamoto Y, Yuasa M, Kaji D, Kageyama K, Nishida A, Ishiwata K, Takagi S, Yamamoto G, Asano-Mori Y, Uchida N, Hishinuma A, Izutsu K, Wake A, Taniguchi S, Yoneyama A. Kimura M, et al. Among authors: nishida a. BMC Infect Dis. 2016 Aug 5;16:372. doi: 10.1186/s12879-016-1692-y. BMC Infect Dis. 2016. PMID: 27495798 Free PMC article.
Clinical and Microbiological Characteristics of Breakthrough Candidemia in Allogeneic Hematopoietic Stem Cell Transplant Recipients in a Japanese Hospital.
Kimura M, Araoka H, Yamamoto H, Asano-Mori Y, Nakamura S, Yamagoe S, Ohno H, Miyazaki Y, Abe M, Yuasa M, Kaji D, Kageyama K, Nishida A, Ishiwata K, Takagi S, Yamamoto G, Uchida N, Izutsu K, Wake A, Taniguchi S, Yoneyama A. Kimura M, et al. Among authors: nishida a. Antimicrob Agents Chemother. 2017 Mar 24;61(4):e01791-16. doi: 10.1128/AAC.01791-16. Print 2017 Apr. Antimicrob Agents Chemother. 2017. PMID: 28115352 Free PMC article.
Successful Treatment of Pulmonary Mucormycosis Caused by Cunninghamella bertholletiae with High-Dose Liposomal Amphotericin B (10 mg/kg/day) Followed by a Lobectomy in Cord Blood Transplant Recipients.
Ota H, Yamamoto H, Kimura M, Araoka H, Fujii T, Umeyama T, Ohno H, Miyazaki Y, Kaji D, Taya Y, Nishida A, Ishiwata K, Tsuji M, Takagi S, Asano-Mori Y, Yamamoto G, Uchida N, Izutsu K, Masuoka K, Wake A, Yoneyama A, Makino S, Taniguchi S. Ota H, et al. Among authors: nishida a. Mycopathologia. 2017 Oct;182(9-10):847-853. doi: 10.1007/s11046-017-0149-1. Epub 2017 Jun 2. Mycopathologia. 2017. PMID: 28577122
No post-transplant pure red cell aplasia development in 106 major ABO incompatible cord blood transplantation.
Wada S, Asano-Mori Y, Yamamoto H, Yuasa M, Kageyama K, Kaji D, Nishida A, Ishiwata K, Takagi S, Yamamoto G, Uchida N, Yoneyama A, Makino S, Taniguchi S. Wada S, et al. Among authors: nishida a. Bone Marrow Transplant. 2019 May;54(5):765-768. doi: 10.1038/s41409-018-0375-2. Epub 2018 Nov 6. Bone Marrow Transplant. 2019. PMID: 30401968 Clinical Trial. No abstract available.
HHV-6 associated diseases are one of the major factors on higher early CNS complications in CB recipients than in those of BM/PBSC.
Kageyama K, Uchida N, Yamamoto H, Takagi S, Ebihara M, Yuasa M, Kaji D, Nishida A, Ishiwata K, Yamamoto G, Asano-Mori Y, Izutsu K, Wake A, Yoneyama A, Makino S, Taniguchi S. Kageyama K, et al. Among authors: nishida a. Bone Marrow Transplant. 2021 Mar;56(3):686-688. doi: 10.1038/s41409-020-01028-5. Epub 2020 Aug 11. Bone Marrow Transplant. 2021. PMID: 32782352 No abstract available.
Prognostic Impact of Cytogenetic Evolution on the Outcome of Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia in Nonremission: A Single-Institute Analysis of 212 Recipients.
Yuasa M, Yamamoto H, Mitsuki T, Kageyama K, Kaji D, Taya Y, Nishida A, Ishiwata K, Takagi S, Yamamoto G, Asano-Mori Y, Wake A, Koike Y, Makino S, Uchida N, Taniguchi S. Yuasa M, et al. Among authors: nishida a. Biol Blood Marrow Transplant. 2020 Dec;26(12):2262-2270. doi: 10.1016/j.bbmt.2020.08.026. Epub 2020 Aug 29. Biol Blood Marrow Transplant. 2020. PMID: 32871257 Free article.
882 results